we don't need the researcher and his degrees, but the double blind study to establishes its validity, and tests its side effects. i hope it works, but on the basis of what you sent, gloria, it's not really confidence establishing yet
ken
kenneth harrow
professor emeritus
dept of english
michigan state university
517 803-8839
harrow@msu.edu
From: usaafricadialogue@googlegroups.com <usaafricadialogue@googlegroups.com> on behalf of Gloria Emeagwali <gloria.emeagwali@gmail.com>
Sent: Sunday, April 26, 2020 2:09 PM
To: usaafricadialogue@googlegroups.com <usaafricadialogue@googlegroups.com>
Subject: USA Africa Dialogue Series - Covid Organics
Sent: Sunday, April 26, 2020 2:09 PM
To: usaafricadialogue@googlegroups.com <usaafricadialogue@googlegroups.com>
Subject: USA Africa Dialogue Series - Covid Organics
http://venturesafrica.com/madagascar-launches-covid-organics-as-a-remedy-for-the-novel-coronavirus/
-- Behind "covid organics" is a researcher with a diploma in Medicine from the University of Kinshasa and degrees from two other universities.. He was recruited by the World Health Organization to do research. Dr. Jarome Muyangui (Jerome Muyangi) of Congo is now reaping the benefits of his research on the ARTEMISIA plant after receiving death threats for his work.
Listserv moderated by Toyin Falola, University of Texas at Austin
To post to this group, send an email to USAAfricaDialogue@googlegroups.com
To subscribe to this group, send an email to USAAfricaDialogue+subscribe@googlegroups.com
Current archives at http://groups.google.com/group/USAAfricaDialogue
Early archives at http://www.utexas.edu/conferences/africa/ads/index.html
---
You received this message because you are subscribed to the Google Groups "USA Africa Dialogue Series" group.
To unsubscribe from this group and stop receiving emails from it, send an email to usaafricadialogue+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/usaafricadialogue/CAMkN8apwmDRuA6e8QeY13_Fg80NZ2yjbL1WmDXxp2Kqr2d1%2BKQ%40mail.gmail.com.
No comments:
Post a Comment